
|Slideshows|August 5, 2016 (Updated: November 11, 2020)
Spotlight on New Oncology Drugs: Access, Costs, and Use
Author(s)Cancer Network Editors
Read compelling analyses of 5-year trends and projected changes in the oncology clinical drug pipeline, selected from the IMS Institute for Healthcare Informatics’ recent “Global Oncology Trend Report.”
Advertisement
Slides republished with permission from the IMS Institute for Healthcare Informatics. Visit theimsinstitute.org to view the full publication, “Global Oncology Trend Report: A Review of 2015 and Outlook to 2020.”
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Potential Iberdomide Approval May Offer Another Choice in Multiple Myeloma
2
Adding 177Lu-PSMA-617 to ADT Plus ARPI Improves Radiographic PFS in mHSPC
3
Adding SBRT to Ipilimumab/Nivolumab Does Not Improve PFS in Advanced RCC
4
Belzutifan Regimen Boosts Responses, PFS in Clear Cell RCC
5



















































